Staging the Oncology Patient Laura Brockley | Default

www.vet-webinar.com utilise des cookies pour vous offrir le meilleur service possible. Lire plus

Panier
Français
Deutsch
English
Español
Français

Detail

staging-the-oncology-patient.png

Staging the Oncology Patient

Durée: 0:57 h
Intervenant(e): Laura Brockley
à partir de 1 US$ 46,20
(incl. TVA)
Description

Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.

Recording from 8 April 2020

 

Laura_photo_resized.jpg
Laura Brockley

Dr Laura Brockley BVSc, MANZCVS, FANZCVS

Dr Laura Brockley obtained her Bachelor of Veterinary Science with honours from the University of Melbourne in 2001.  She initially worked in small animal and mixed practices in Victoria and the United Kingdom, including teaching students at the Royal College in London.  Laura completed an internship and residency in Veterinary Oncology at the Melbourne Veterinary Specialist Centre in 2011.  In 2013 she became a registered specialist in Veterinary Oncology (Fellow of the Australian and New Zealand College of Veterinary Scientists).  Laura has a strong clinical interest in immunotherapy, lymphoma diagnostics and treatment, and using evidence-based medicine to provide compassionate care to cancer patients.  She advocates spending the time to ensure pet owners are making an informed decision on treatment options ranging from palliative to potentially curative in intent. Laura is actively involved in continuing education, including lecturing Veterinary nursing students and examining our next generation of oncology specialists.

Précédent

Vous pourriez également être intéressé(e) par

veterinary-gb0489bee6_1920300x200.jpg

Supportive Care for Cancer Patients for Nurses
How to provide the best nursing care for patients with cancer 
Détails
Durée: 0:51 h
Intervenant(e): Penny Thomas
tumor-grading-and-prognosis-in-veterinary-practice-1.jpeg

Tumor grading and prognosis in veterinary practice
Tumors are quite frequent in companion animals, with malignant forms representing 56% of all the tumors in dogs and 80% in cats. Predicting the survival time and treatment response for malignant tumors is necessary to evaluate the best care options for the animal. Histological tumor grading helps veterinarians to define the prognosis, but each tumor has its own grading system with different prognosis, in terms of survival rate, metastatic rate, recurrence incidence. It could be not so easy to get your bearings in the pathologic words of gradings. The goal of this seminar is to be able to correlate the validated prognosis to each tumor grading we will see. We will rapidly review what tumor grading is and how it is evaluated. Then we will spend some time to review some of the most important tumor gradings (mammary tumors, mast cell tumors, melanomas, soft tissue sarcomas) and the correlated and validated prognostic factors. At the end of the seminar you will be able to clearly understand your pathologist’s report based on the grading system, and to use it to give an appropriate prognosis to the owners.
Détails
Durée: 0:44 h
Intervenant(e): Sara Belluco
canine-and-feline-lymphoma-diagnosis-and-treatment-1.jpeg

Canine and feline lymphoma - diagnosis and treatment
Canine and feline lymphoma is a relatively common disease but there are some areas where potential complications arise. This webinar will concentrate on the diagnostic tests that can be utilised for this disease and the common treatments, with an emphasis on how the diagnostic tests can influence the treatment and prognosis. In dogs, diagnosis is usually relatively straightforward, but it can be more of a challenge in cats due to the differences in clinical presentation. The standard initial treatment options are well described, but how they need to be modified dependent on concurrent illnesses, diagnostic test findings and owner constraints can be more complicated. My approach to these issues will be described including how they might impact the patient outcome, as well as alternatives. The monitoring of the patients and an overview of the management of complications of the disease and treatment is to be covered. The webinar will conclude with rescue options. Lymphoma can be a rewarding disease to treat, but can be very challenging at times.
Détails
Durée: 0:59 h
Intervenant(e): Peter Bennett